No difference in prognosis between atypical intradermal smooth muscle neoplasms and dermal leiomyosarcoma: Local recurrence, metastasis, and overall survival in a nationwide cohort of 423 patients - 19/02/25
, Erik E.F. Bak, BMSc a, Andreas Larsen, MD a, Anne Lene Wagenblast, MD a, Grethe Schmidt, MD a, David Hebbelstrup Jensen, MD, PhD a, Michael M. Petersen, MD, DMSc b, c, Anand C. Loya, MD d, Søren Daugaard, MD d, Mikkel Herly, MD, PhD a, e, Jason L. Hornick, MD, PhD f, Thomas Mentzel, MD g, Peter Vester-Glowinski, MD, PhD a, cKey words : atypical intradermal smooth muscle neoplasms, cancer, cutaneous leiomyosarcoma, dermal leiomyosarcoma, dermatology, epidemiology, follow-up, local recurrence, metastasis, oncology, overall survival, prognosis, sarcoma, skin cancer
| Drs Abebe and Ørholt contributed equally to this study. |
|
| Funding sources: This study was funded by the Danish Medical Society (DMS). |
|
| Patient consent: Not applicable (nonidentifiable register-based data). |
|
| IRB approval status: Not applicable. |
Vol 92 - N° 3
P. 569-572 - mars 2025 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
